出血的预防的临床试验
总计29785个结果
-
Hyloris Developments招聘中
-
Swansea University完全的
-
Roxane Laboratories完全的
-
Bayer主动,不招人甲型血友病 | 孩子们 | 出血的预防 | 出血的治疗加拿大, 美国, 巴西, 意大利, 火鸡, 阿根廷, 挪威
-
Scripps Translational Science Institute完全的
-
Duke UniversityOrthopedic Research and Education Foundation; American Association of Hip and Knee Surgeons招聘中
-
Ospedale Regina ApostolorumAzienda Ospedaliera San Gerardo di Monza; San Giuseppe Moscati Hospital; Ospedali Riuniti di Foggia未知
-
Beth Israel Deaconess Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); ViiV... 和其他合作者招聘中
-
Institute of Hematology & Blood Diseases Hospital尚未招聘人源化 CD25 抗体在 HID-HSCT 老年患者预防 aGVHD 中的有效性和安全性
-
Novartis Pharmaceuticals完全的接受同种异体肾移植患者急性排斥反应的预防西班牙
-
Centre Hospitalier Universitaire de Nice招聘中
-
GlaxoSmithKline完全的
-
Johann Wolfgang Goethe University Hospital未知Anticoagulant Prophylaxis/Therapy德国
-
Alexion Pharmaceuticals, Inc.Portola Pharmaceuticals, LLC (a wholly owned subsidiary of Alexion Pharmaceuticals)终止
-
Simon GregsonNational Institute of Mental Health (NIMH); University of Copenhagen; London School of Economics... 和其他合作者完全的
-
Hôpital Edouard HerriotCapso Vision, Inc.完全的贫血 | 息肉 | 血管发育不良 | 消化道出血 | 梅莱娜
-
ThromboGenicsBioInvent International AB完全的
-
Kanuni Sultan Suleyman Training and Research Hospital主动,不招人
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation主动,不招人
-
Institute of Hematology & Blood Diseases Hospital尚未招聘评估巨细胞病毒再激活二级预防的有效性和安全性
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)招聘中
-
Edward GeisslerExcelya; Chiesi Pharmaceuticals GmbH主动,不招人
-
University of Toronto完全的
-
Heinz Italia SpAUniversity of Cagliari; IRCCS Policlinico S. Matteo完全的